0.252 USD
0 (-1.45%)
0.2577 USD
+0.01 (+2.26%)
Overall ZJYL gets a fundamental rating of 3 out of 10. We evaluated ZJYL against 188 industry peers in the Health Care Equipment & Supplies industry. ZJYL has a medium profitability rating, but doesn't score so well on its financial health evaluation. ZJYL does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year ZJYL was profitable.
In the past year ZJYL had a positive cash flow from operations.
ZJYL had positive earnings in each of the past 5 years.
Of the past 5 years ZJYL 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.69%, ZJYL is in the better half of the industry, outperforming 79.26% of the companies in the same industry.
With a decent Return On Equity value of 6.42%, ZJYL is doing good in the industry, outperforming 79.79% of the companies in the same industry.
The Return On Invested Capital of ZJYL (3.84%) is better than 72.87% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ZJYL is in line with the industry average of 8.71%.
The 3 year average ROIC (9.49%) for ZJYL is well above the current ROIC(3.84%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.69% | ||
| ROE | 6.42% | ||
| ROIC | 3.84% |
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
1.3 Margins
ZJYL has a Profit Margin of 7.85%. This is in the better half of the industry: ZJYL outperforms 79.79% of its industry peers.
ZJYL's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 8.57%, ZJYL is doing good in the industry, outperforming 76.60% of the companies in the same industry.
In the last couple of years the Operating Margin of ZJYL has declined.
ZJYL has a worse Gross Margin (35.79%) than 70.74% of its industry peers.
ZJYL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.57% | ||
| PM (TTM) | 7.85% | ||
| GM | 35.79% |
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZJYL is creating some value.
Compared to 1 year ago, ZJYL has more shares outstanding
Compared to 5 years ago, ZJYL has less shares outstanding
ZJYL has a worse debt/assets ratio than last year.
2.2 Solvency
ZJYL has an Altman-Z score of 2.99. This is not the best score and indicates that ZJYL is in the grey zone with still only limited risk for bankruptcy at the moment.
ZJYL has a Altman-Z score of 2.99. This is in the better half of the industry: ZJYL outperforms 69.15% of its industry peers.
ZJYL has a Debt/Equity ratio of 0.56. This is a neutral value indicating ZJYL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.56, ZJYL is not doing good in the industry: 61.70% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.99 |
ROIC/WACC0.57
WACC6.74%
2.3 Liquidity
ZJYL has a Current Ratio of 2.11. This indicates that ZJYL is financially healthy and has no problem in meeting its short term obligations.
ZJYL's Current ratio of 2.11 is on the low side compared to the rest of the industry. ZJYL is outperformed by 61.70% of its industry peers.
ZJYL has a Quick Ratio of 1.90. This is a normal value and indicates that ZJYL is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.90, ZJYL perfoms like the industry average, outperforming 47.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
The earnings per share for ZJYL have decreased strongly by -39.04% in the last year.
The Earnings Per Share has been growing slightly by 3.28% on average over the past years.
ZJYL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.42%.
The Revenue has been growing slightly by 2.90% on average over the past years.
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 25.20 indicates a quite expensive valuation of ZJYL.
Based on the Price/Earnings ratio, ZJYL is valued a bit cheaper than the industry average as 78.72% of the companies are valued more expensively.
ZJYL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.2 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -4.88 |
4.3 Compensation for Growth
ZJYL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)7.69
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ZJYL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.252
0 (-1.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.45%
Inst Owner Change-66.97%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap39.45M
Revenue(TTM)22.83M
Net Income(TTM)1.79M
AnalystsN/A
Price TargetN/A
Short Float %1.74%
Short Ratio0.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.2 | ||
| Fwd PE | N/A | ||
| P/S | 1.73 | ||
| P/FCF | N/A | ||
| P/OCF | 30.24 | ||
| P/B | 1.41 | ||
| P/tB | 1.47 | ||
| EV/EBITDA | -4.88 |
EPS(TTM)0.01
EY3.97%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.01
OCFY3.31%
SpS0.15
BVpS0.18
TBVpS0.17
PEG (NY)N/A
PEG (5Y)7.69
Graham Number0.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.69% | ||
| ROE | 6.42% | ||
| ROCE | 7.04% | ||
| ROIC | 3.84% | ||
| ROICexc | 13.32% | ||
| ROICexgc | 14.59% | ||
| OM | 8.57% | ||
| PM (TTM) | 7.85% | ||
| GM | 35.79% | ||
| FCFM | N/A |
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
ROICexc(3y)22.47%
ROICexc(5y)22.7%
ROICexgc(3y)23.46%
ROICexgc(5y)23.49%
ROCE(3y)12.88%
ROCE(5y)15.84%
ROICexgc growth 3Y-2.39%
ROICexgc growth 5Y-7.19%
ROICexc growth 3Y-4.58%
ROICexc growth 5Y-8.54%
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
F-Score4
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.13 | ||
| Cap/Depr | 847.75% | ||
| Cap/Sales | 9.25% | ||
| Interest Coverage | 5.51 | ||
| Cash Conversion | 59.19% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.9 | ||
| Altman-Z | 2.99 |
F-Score4
WACC6.74%
ROIC/WACC0.57
Cap/Depr(3y)178.09%
Cap/Depr(5y)117.95%
Cap/Sales(3y)1.86%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.9%
EBIT growth 3Y11.4%
EBIT growth 5Y-3.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.18%
OCF growth 3YN/A
OCF growth 5YN/A
JIN MEDICAL INTERNATIONAL LT / ZJYL FAQ
Can you provide the ChartMill fundamental rating for JIN MEDICAL INTERNATIONAL LT?
ChartMill assigns a fundamental rating of 3 / 10 to ZJYL.
Can you provide the valuation status for JIN MEDICAL INTERNATIONAL LT?
ChartMill assigns a valuation rating of 1 / 10 to JIN MEDICAL INTERNATIONAL LT (ZJYL). This can be considered as Overvalued.
What is the profitability of ZJYL stock?
JIN MEDICAL INTERNATIONAL LT (ZJYL) has a profitability rating of 6 / 10.
What are the PE and PB ratios of JIN MEDICAL INTERNATIONAL LT (ZJYL) stock?
The Price/Earnings (PE) ratio for JIN MEDICAL INTERNATIONAL LT (ZJYL) is 25.2 and the Price/Book (PB) ratio is 1.41.